Viswanath Gunda

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Combination BRAF V600E Inhibition with the Multitargeting Tyrosine Kinase Inhibitor Axitinib Shows Additive Anticancer Activity in BRAF V600E -Mutant Anaplastic Thyroid Cancer”.

Combination BRAF V600E Inhibition with the Multitargeting Tyrosine Kinase Inhibitor Axitinib Shows Additive Anticancer Activity in BRAF V600E -Mutant Anaplastic Thyroid Cancer

Thyroid(2023)10.1089/thy.2023.0201

N/A

0DataRank · unranked

15 citations

Chandrayee Ghosh, Jiangnan Hu, Lisa Zhang, Ya -Qin Zhang, Min Shen +2 more

Combination nitazoxanide and auranofin treatment has synergistic anticancer activity in anaplastic thyroid cancer through enhanced activation of oxidative stress that leads to apoptosis

Cancer Letters(2025)10.1016/j.canlet.2025.217990

N/A

0DataRank · unranked

5 citations

Tejinder Pal Khaket, Viswanath Gunda, Zhongyue Yang, Jiangnan Hu, Eden Demissie Alamaw +8 more